350
Participants
Start Date
March 30, 2021
Primary Completion Date
April 19, 2024
Study Completion Date
April 19, 2024
(RS)-baclofen, naltrexone hydrochloride and D-sorbitol
oral fixed dose combination
Placebo
liquid oral solution
Universitaire Ziekenhuizen Leuven, Leuven
Colombia University Department of Neurology, New York
Service de Neurologie et Maladies Neuromusculaires, CHU de Marseille - Hopital La Timone, Marseille
Complejo Hospitalario Universitario de Santiago, Santiago de Compostela
Azienda Ospedaliera Universitaria San Martino Universita Degli Studi di Genova Clinica Neurologica, Genova
UNC Department of Neurology Peripheral Neuropathy Center, Chapel Hill
Hospital Universitario Clinico San Carlos, Madrid
Atrium Health Neurosciences Institute, Charlotte
University of Florida Clinical Research Center, Gainesville
Advent Health Medical Group Neurology Orlando, Orlando
Centre de reference des maladies neuromusculaires AOC Hopital Pellegrin CHU de Bordeaux, Bordeaux
University of Miami Leonard M. Miller School of Medicine, Miami
University Hospital GB Rossi UOC Neurologia B, AOUI Verona Department of Neuroscience, Biomedicine and Movement Sciences, Verona
Hospital Universitario Virgen del Rocío, Seville
The Ohio State University Wexner Medical Center, Columbus
Hospital Universitario y Politécnico La Fé, Valencia
University Hospital Muenster UKM Department of Neurology, Münster
Centre de Reference des Maladies Neuromusculaires AOC Service de Neurologie, CHU d'Angers, Angers
Sheba Medical Center, Ramat Gan
University of Minnesota Health, Minneapolis
CHU de Lille Hôpital Salengro, Lille
MU Health Care Neurology and Sleep Disorders Clinic, Columbia
University of Kansas Medical Center Research Institute, Fairway
Centre d'investigation Clinique CHU de Strasbourg Hopital de Hautepierre, Strasbourg
Universitätsklinikum Tübingen Crona Kliniken Neuromuskuläres Zentrum, Tübingen
Association lnstitut de Myologie Hopital Pitie-Salpetriere Service de Neuro-Myologie, Paris
National Neuromuscular Research Institute, Austin
University of Naples Federico II, Naples
Cedars-Sinai Medical Center, Los Angeles
UCLA Department of Psychiatry and Biobehavioral Sciences, Los Angeles
Hadassah Ein Kerem University Medical Center Department of Neurology, Jerusalem
UC Davis Health Department of Physical Medicine and Rehabilitation, Sacramento
Oregon Neurology, Springfield
"Azienda Ospedaliera Universitaria Policlinico G. Martino di Messina", Messina
Neurology Clinic at University of Washington Medical Center, Seattle
Providence St. Luke's Rehabilitation Medical Center, Spokane
Tel Aviv Sourasky Medical Center, Tel Aviv
Hospital for Special Care, New Britain
Massachusetts General Hospital Neuromuscular Diagnostic Center, Boston
Hackensack Meridian Health Hackensack University Medical Center, Hackensack
Ottawa Hospital Research Institute- Neuromuscular Research Centre, Ottawa
UHN Toronto General Hospital Krembil Neuroscience Centre, Toronto
CIUSS de Saguenay-Lac-Saint-Jean Centre d'etudes Cliniques, Chicoutimi
Montreal Neurological Institute and Hospital-Clinical Research Unit, Montreal
CHU de Quebec-Universite Laval- Hopital Enfant-Jesus, Québec
Rigshospitalet, University of Copenhagen Copenhagen Neuromuscular Center, Copenhagen
University Hospital RWTH Aachen, Department of Neurology and Institute for Neuropathology, Aachen
University Medical Centre Goettingen, Dept. of Clinical Neurology, Göttingen
Friedrich-Baur-Institut, Neurologische Klinik und Poliklinik Ludwig-Maximilians-Universität, München
Tor Vergata University of Rome, Rome
Collaborators (1)
Worldwide Clinical Trials
OTHER
Pharnext S.C.A.
OTHER